Related references
Note: Only part of the references are listed.CNS inflammation and neurodegeneration
Tanuja Chitnis et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Current view and perspectives in amyotrophic lateral sclerosis
Stephane Mathis et al.
NEURAL REGENERATION RESEARCH (2017)
ALS Pathogenesis and Therapeutic Approaches: The Role of Mesenchymal Stem Cells and Extracellular Vesicles
Roberta Bonafede et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
APP as a Protective Factor in Acute Neuronal Insults
Dimitri Hefter et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Parkinson disease
Werner Poewe et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
O-GlcNAc Glycosylation of nNOS Promotes Neuronal Apoptosis Following Glutamate Excitotoxicity
Rongrong Chen et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2017)
Emerging (and converging) pathways in Parkinson's disease: keeping mitochondrial wellness
Domenico Cieri et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Calcium and Parkinson's disease
D. James Surmeier et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer's disease mouse model
Romain Fol et al.
ACTA NEUROPATHOLOGICA (2016)
Altered Kynurenine Pathway Metabolism in Autism: Implication for Immune-Induced Glutamatergic Activity
Chai K. Lim et al.
AUTISM RESEARCH (2016)
Mechanisms of tau and Aβ-induced excitotoxicity
Susanne P. Pallo et al.
BRAIN RESEARCH (2016)
Serum levels of SOD and risk of autism spectrum disorder: A case-control study
Lixuan Wang et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2016)
Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis
Emiliano Trias et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Oral Inosine Persistently Elevates Plasma antioxidant capacity in Parkinson's disease
Shamik Bhattacharyya et al.
MOVEMENT DISORDERS (2016)
Molecular mechanisms of NMDA receptor-mediated excitotoxicity: implications for neuroprotective therapeutics for stroke
Victor Li et al.
NEURAL REGENERATION RESEARCH (2016)
Elevated plasma levels of glutamate in children with autism spectrum disorders
Jing Cai et al.
NEUROREPORT (2016)
Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis
Rosa Luisa Potenza et al.
NEUROTHERAPEUTICS (2016)
Adult Neurogenesis and Psychiatric Disorders
Eunchai Kang et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation
L. Brundin et al.
TRANSLATIONAL PSYCHIATRY (2016)
Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies
Pradip K. Kamat et al.
MOLECULAR NEUROBIOLOGY (2016)
Pathophysiological Role of Neuroinflammation in Neurodegenerative Diseases and Psychiatric Disorders
Heeok Hong et al.
INTERNATIONAL NEUROUROLOGY JOURNAL (2016)
Dynamics and modulation of metabotropic glutamate receptors
Philippe Rondard et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
Striatal astrocytes produce neuroblasts in an excitotoxic model of Huntington's disease
Giulia Nato et al.
DEVELOPMENT (2015)
Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Adults Aged 20-64 Years in 1990-2013: Data from the Global Burden of Disease 2013 Study
Rita V. Krishnamurthi et al.
NEUROEPIDEMIOLOGY (2015)
Mechanisms of Neuronal Protection against Excitotoxicity, Endoplasmic Reticulum Stress, and Mitochondrial Dysfunction in Stroke and Neurodegenerative Diseases
Howard Prentice et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
Adult Neurogenesis in Neurodegenerative Diseases
Beate Winner et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2015)
The Global Burden of Mental, Neurological and Substance Use Disorders: An Analysis from the Global Burden of Disease Study 2010
Harvey A. Whiteford et al.
PLOS ONE (2015)
Quinolinic Acid Responses during Interferon-α-Induced Depressive Symptomatology in Patients with Chronic Hepatitis C Infection - A Novel Aspect for Depression and Inflammatory Hypothesis
Andreas Baranyi et al.
PLOS ONE (2015)
Ketamine and other glutamate receptor modulators for depression in adults
Caroline Caddy et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
Mitochondrial permeability transition pore is a potential drug target for neurodegeneration
Valasani Koteswara Rao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Mfn2 downregulation in excitotoxicity causes mitochondrial dysfunction and delayed neuronal death
Alejandro Martorell-Riera et al.
EMBO JOURNAL (2014)
Glutamate-mediated excitotoxicity in schizophrenia: A review
Eric Plitman et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex
W. Zhou et al.
EUROPEAN PSYCHIATRY (2014)
The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013
Zachary Steel et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2014)
Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression?
Robert Dantzer et al.
JOURNAL OF NEURAL TRANSMISSION (2014)
GABAergic/glutamatergic imbalance relative to excessive neuroinflammation in autism spectrum disorders
Afaf El-Ansary et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Perspectives on neuroinflammation and excitotoxicity: A neurotoxic conspiracy?
Barbara Viviani et al.
NEUROTOXICOLOGY (2014)
A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease No Evidence of Benefit
M. Flint Beal et al.
JAMA NEUROLOGY (2014)
Increased Glutamate Concentration in the Auditory Cortex of Persons With Autism and First-Degree Relatives: A 1H-MRS Study
Mark S. Brown et al.
AUTISM RESEARCH (2013)
Activation of Mammalian Target of Rapamycin and Synaptogenesis: Role in the Actions of Rapid-Acting Antidepressants
Jason M. Dwyer et al.
BIOLOGICAL PSYCHIATRY (2013)
Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
Ali Ghaleiha et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Calcium, Bioenergetics, and Neuronal Vulnerability in Parkinson's Disease
D. James Surmeier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Neuroinflammation and psychiatric illness
Souhel Najjar et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Phase II Safety, Tolerability, and Dose Selection Study of Isradipine as a Potential Disease-Modifying Intervention in Early Parkinson's Disease (STEADY-PD)
Tanya Simuni
MOVEMENT DISORDERS (2013)
Connecting Inflammation with Glutamate Agonism in Suicidality
Sophie Erhardt et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Conceptual Confluence: The Kynurenine Pathway as a Common Target for Ketamine and the Convergence of the Inflammation and Glutamate Hypotheses of Depression
Andrew H. Miller
NEUROPSYCHOPHARMACOLOGY (2013)
INFLAMMATORY CYTOKINES IN DEPRESSION: NEUROBIOLOGICAL MECHANISMS AND THERAPEUTIC IMPLICATIONS
J. C. Felger et al.
NEUROSCIENCE (2013)
Excitotoxicity in the Pathogenesis of Autism
M. M. Essa et al.
NEUROTOXICITY RESEARCH (2013)
Increased Hippocampal Glutamate and Volumetric Deficits in Unmedicated Patients With Schizophrenia
Nina V. Kraguljac et al.
JAMA PSYCHIATRY (2013)
Elevated Prefrontal Cortex γ-Aminobutyric Acid and Glutamate-Glutamine Levels in Schizophrenia Measured In Vivo With Proton Magnetic Resonance Spectroscopy
Lawrence S. Kegeles et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Matrix Metalloproteinases, New Insights into the Understanding of Neurodegenerative Disorders
Yoon-Seong Kim et al.
BIOMOLECULES & THERAPEUTICS (2012)
Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine - searching for the connections
Wojciech Danysz et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Quinolinic acid, the inescapable neurotoxin
Gilles J. Guillemin
FEBS JOURNAL (2012)
The role of the kynurenine metabolism in major depression
Aye-Mu Myint et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine- induced psychopathology
J. M. Stone et al.
MOLECULAR PSYCHIATRY (2012)
Kynurenines in the mammalian brain: when physiology meets pathology
Robert Schwarcz et al.
NATURE REVIEWS NEUROSCIENCE (2012)
GABAergic interneuron origin of schizophrenia pathophysiology
Kazu Nakazawa et al.
NEUROPHARMACOLOGY (2012)
Synapses and Alzheimer's Disease
Morgan Sheng et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Soluble amyloid precursor protein-α modulates β-secretase activity and amyloid-β generation
Demian Obregon et al.
NATURE COMMUNICATIONS (2012)
Trafficking and Proteolytic Processing of APP
Christian Haass et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Metabotropic Glutamate Receptor 5 Upregulation in Children with Autism is Associated with Underexpression of Both Fragile X Mental Retardation Protein and GABAA Receptor Beta 3 in Adults with Autism
S. Hossein Fatemi et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2011)
Meta-Analysis of the Efficacy of Adjunctive NMDA Receptor Modulators in Chronic Schizophrenia
Surendra P. Singh et al.
CNS DRUGS (2011)
Tolerability and efficacy of memantine add-on therapy to rivastigmine transdermal patches in mild to moderate Alzheimer's disease: a multicenter, randomized, open-label, parallel-group study
Seong Hye Choi et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Nitric oxide signaling: Classical, less classical, and nonclassical mechanisms
Antonio Martinez-Ruiz et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission?
Johann Steiner et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Amyloid-β/Fyn-Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease
Erik D. Roberson et al.
JOURNAL OF NEUROSCIENCE (2011)
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Anita E. Autry et al.
NATURE (2011)
Family-based association testing of glutamate transporter genes in autism
Suma Jacob et al.
PSYCHIATRIC GENETICS (2011)
I live a life of frustration ... Individual with Parkinson's disease
Melinda Hermanns
JOURNAL OF CHRISTIAN NURSING (2011)
Oxidative stress caused by mitochondrial calcium overload
Tsung-I Peng et al.
MITOCHONDRIAL RESEARCH IN TRANSLATIONAL MEDICINE (2010)
Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease
Colleen M. Niswender et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Lars M. Ittner et al.
CELL (2010)
Mechanisms Underlying Inflammation in Neurodegeneration
Christopher K. Glass et al.
CELL (2010)
Pathogenic Lysosomal Depletion in Parkinson's Disease
Benjamin Dehay et al.
JOURNAL OF NEUROSCIENCE (2010)
A Double-Blind, Placebo-Controlled Study to Assess the Mitochondria-Targeted Antioxidant MitoQ as a Disease-Modifying Therapy in Parkinson's Disease
Barry J. Snow et al.
MOVEMENT DISORDERS (2010)
Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1
Jaime N. Guzman et al.
NATURE (2010)
Glutamate receptors, neurotoxicity and neurodegeneration
Anthony Lau et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
Interferon-γ and Tumor Necrosis Factor-α Mediate the Upregulation of Indoleamine 2,3-Dioxygenase and the Induction of Depressive-Like Behavior in Mice in Response to Bacillus Calmette-Guerin
Jason C. O'Connor et al.
JOURNAL OF NEUROSCIENCE (2009)
NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation
Angela M. Brennan et al.
NATURE NEUROSCIENCE (2009)
Interplay between Cytosolic Dopamine, Calcium, and α-Synuclein Causes Selective Death of Substantia Nigra Neurons
Eugene V. Mosharov et al.
NEURON (2009)
Novel Neuroprotective Mechanisms of Memantine: Increase in Neurotrophic Factor Release from Astroglia and Anti-Inflammation by Preventing Microglial Activation
Hung-Ming Wu et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Neurochemical changes in the rat prefrontal cortex following acute phencyclidine treatment: an in vivo localized 1H MRS study
Isabelle Iltis et al.
NMR IN BIOMEDICINE (2009)
Linking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis
Scott A. Small et al.
NEURON (2008)
Aβ plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks
Kishore V. Kuchibhotla et al.
NEURON (2008)
Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease
Marc Aurel Busche et al.
SCIENCE (2008)
What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia
Hilleke E. Hulshoff Pol et al.
SCHIZOPHRENIA BULLETIN (2008)
Memantine:: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutarnatergic system -: too little activation is bad, too much is even worse
Chris G. Parsons et al.
NEUROPHARMACOLOGY (2007)
Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease
Jorge J. Palop et al.
NEURON (2007)
Mapping autism risk loci using genetic linkage and chromosomal rearrangements
Peter Szatmari et al.
NATURE GENETICS (2007)
A retrospective study of memantine in children and adolescents with pervasive developmental disorders
Craig A. Erickson et al.
PSYCHOPHARMACOLOGY (2007)
Excitotoxicity and new antiglutamatergic strategies in Parkinson's diseaseand Alzheimer's disease
Eleni Koutsilleri et al.
PARKINSONISM & RELATED DISORDERS (2007)
Increased serum levels of glutamate in adult patients with autism
Atsuko Shinohe et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists
KW Muir
CURRENT OPINION IN PHARMACOLOGY (2006)
Ionotropic and metabotropic glutamate receptor structure and pharmacology
JNC Kew et al.
PSYCHOPHARMACOLOGY (2005)
Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus
G Bonanno et al.
JOURNAL OF NEUROSCIENCE (2005)
Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: A 4-T proton MRS study
LM Rowland et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
The PSD95-nNOS interface: a target for inhibition of excitotoxic p38 stress-activated protein kinase activation and cell death
J Cao et al.
JOURNAL OF CELL BIOLOGY (2005)
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil - A randomized controlled trial
PN Tariot et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
AMPA receptor regulation mechanisms: Future target for safer neuroprotective drugs
SS Jayakar et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2004)
Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity
M Arundine et al.
CELL CALCIUM (2003)
Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice
H Guo et al.
HUMAN MOLECULAR GENETICS (2003)
Cost of lost productive work time among US workers with depression
WF Stewart et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Repeated administration of antidepressants decreases field potentials in rat frontal cortex
B Bobula et al.
NEUROSCIENCE (2003)
Pathogenesis of Parkinson's disease:: Dopamine, vesicles and α-synuclein
J Lotharius et al.
NATURE REVIEWS NEUROSCIENCE (2002)
Postmortem brain abnormalities of the glutamate neurotransmitter system in autism
AE Purcell et al.
NEUROLOGY (2001)
From Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS
DW Cleveland et al.
NATURE REVIEWS NEUROSCIENCE (2001)
Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder
BH King et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2001)
Lamotrigine therapy for autistic disorder: A randomized, double-blind, placebo-controlled trial
KM Belsito et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2001)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Share Paper
